Skip to content

MammoStar™ STAR1102Recalls & reported problems

Carbon Medical Technologies, Inc. · Biopsy Site Identifier · Class 2 · Implant

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00858015005400), received between May 27, 2024 and May 27, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Patient-Device Incompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Patient-Device Incompatibility1
  • Prophylactic removal due to corrective action1

Patient problems

  • Foreign Body Reaction1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 27, 2024Patient-Device Incompatibility; Prophylactic removal due to corrective action; Patient-Device Incompatibility; Prophylactic removal due to corrective action

    A RETROSPECTIVE CHART REVIEW POST MARKET CLINICAL FOLLOW-UP STUDY REPORTED THAT AN FOREIGN BODY REACTION WAS OBSERVED WITH A CAUSAL ASSOCIATION. CLINICAL MANAGEMENT INCLUDED ORAL MEDICATION RESULTING IN A FULL RECOVERY. DESPITE A WARNING IN THE IFU, THE MARKER WAS INSERTED INTO A BLOOD VESSEL.

    Patient problems: Foreign Body Reaction

    MAUDE report 19399249 ↗

Other Marker, Radiographic, Implantable devices

All Marker, Radiographic, Implantable devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.